Evidence map›Paper›PMID 37668621›Full record

ArticleJAMA2023

Eye-Tracking-Based Measurement of Social Visual Engagement Compared With Expert Clinical Diagnosis of Autism.

Warren Jones, Cheryl Klaiman, Shana Richardson, Christa Aoki, Christopher Smith, Mendy Minjarez, Raphael Bernier, Ernest Pedapati, Somer Bishop, Whitney Ence and 4 more

4 registry-linked trialsOpen access · greenAbstract readComparative Study
In one paragraph

Article in JAMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 45 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 6 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03469986 completednot on this map

Prospective, Pivotal, Double-Blinded Within-subject Comparison of the Marcus Autism Center Investigational Device and Current Best Practice Clinical Diagnosis For Autism Spectrum Disorder in Pediatric Subjects 16-30 Months of Age

TypeobservationalSponsorEarliTec Diagnostics, IncRan2018 to 2019Enrolled505ConditionsAutism Spectrum DisorderArmsMarcus Autism Center Investigational Device
NCT04860986 completednot on this map

A Repeatability and Reproducibility Study of the EarliPoint™ Device in Pediatric Subjects 16-30 Months of Age

TypeobservationalSponsorEarliTec Diagnostics, IncRan2021 to 2021Enrolled45ConditionsAutism Spectrum Disorder (ASD)ArmsEarliPoint
NCT05675371 completednot on this map

A Prospective, Multi-Center, Longitudinal Study of Dynamic Quantification of Social-Visual Engagement (DQSVE) For Treatment Monitoring In Children With Autism Spectrum Disorder (ASD).

TypeobservationalSponsorEarliTec Diagnostics, IncRan2023 to 2025Enrolled325ConditionsAutism Spectrum Disorder, Autism, Developmental Delay, Autism, Early InfantileArmsAssessment by Expert Clinician During Behavioral Intervention (ABA or similar), Assessment by the EarliPoint Assessment For Autism Spectrum Disorder
NCT05806216 completednot on this map

A Prospective, Multi-Center Study of Dynamic Quantification of Social-Visual Engagement (DQSVE) in Autism Spectrum Disorder (ASD): Diagnosis and Assessment For Children

TypeobservationalSponsorEarliTec Diagnostics, IncRan2023 to 2025Enrolled929ConditionsAutism Spectrum Disorder, AutismArmsEarliPoint Diagnosis, Clinically Certain Expert Clinician Diagnosis (CC-ECD)
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 6 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Data-Driven Approaches for Autism Detection: A Comprehensive Review of Machine Learning Algorithms and Datasets.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Eye Tracking as a Treatment Monitoring Tool for Autism: A Multilevel Meta-Analysis.Autism research : official journal of the International Society for Autism Research · 2025
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Warren JonesMarcus Autism Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Cheryl KlaimanMarcus Autism Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Shana RichardsonMarcus Autism Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Christa AokiMarcus Autism Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Christopher SmithSouthwest Autism Research & Resource Center, Phoenix, Arizona.
Mendy MinjarezSeattle Children's Autism Center and Department of Psychiatry, University of Washington, Seattle.
Raphael BernierSeattle Children's Autism Center and Department of Psychiatry, University of Washington, Seattle.
Ernest PedapatiCincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Somer BishopUniversity of California San Francisco.
Whitney EnceUniversity of California San Francisco.
Allison WainerRush University Medical Center, Chicago, Illinois.
Jennifer MoriuchiRush University Medical Center, Chicago, Illinois.
Sew-Wah TayLibra Medical Inc, Minneapolis, Minnesota.
Ami KlinMarcus Autism Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
Emory University · USChildren's Healthcare of Atlanta · USRush University Medical Center · USUniversity of California, San Francisco · USUniversity of Washington · USCincinnati Children's Hospital Medical Center · USSouthwest Autism Research & Resource Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: In the US, children with signs of autism often experience more than 1 year of delay before diagnosis and often experience longer delays if they are from racially, ethnically, or economically disadvantaged backgrounds. Most diagnoses are also received without use of standardized diagnostic instruments. To aid in early autism diagnosis, eye-tracking measurement of social visual engagement has shown potential as a performance-based biomarker. Objective: To evaluate the performance of eye-tracking measurement of social visual engagement (index test) relative to expert clinical diagnosis in young children referred to specialty autism clinics. Design, Setting, and Participants: In this study of 16- to 30-month-old children enrolled at 6 US specialty centers from April 2018 through May 2019, staff blind to clinical diagnoses used automated devices to measure eye-tracking-based social visual engagement. Expert clinical diagnoses were made using best practice standardized protocols by specialists blind to index test results. This study was completed in a 1-day protocol for each participant. Main Outcomes and Measures: Primary outcome measures were test sensitivity and specificity relative to expert clinical diagnosis. Secondary outcome measures were test correlations with expert clinical assessments of social disability, verbal ability, and nonverbal cognitive ability. Results: Eye-tracking measurement of social visual engagement was successful in 475 (95.2%) of the 499 enrolled children (mean [SD] age, 24.1 [4.4] months; 38 [8.0%] were Asian; 37 [7.8%], Black; 352 [74.1%], White; 44 [9.3%], other; and 68 [14.3%], Hispanic). By expert clinical diagnosis, 221 children (46.5%) had autism and 254 (53.5%) did not. In all children, measurement of social visual engagement had sensitivity of 71.0% (95% CI, 64.7% to 76.6%) and specificity of 80.7% (95% CI, 75.4% to 85.1%). In the subgroup of 335 children whose autism diagnosis was certain, sensitivity was 78.0% (95% CI, 70.7% to 83.9%) and specificity was 85.4% (95% CI, 79.5% to 89.8%). Eye-tracking test results correlated with expert clinical assessments of individual levels of social disability (r = -0.75 [95% CI, -0.79 to -0.71]), verbal ability (r = 0.65 [95% CI, 0.59 to 0.70]), and nonverbal cognitive ability (r = 0.65 [95% CI, 0.59 to 0.70]). Conclusions and Relevance: In 16- to 30-month-old children referred to specialty clinics, eye-tracking-based measurement of social visual engagement was predictive of autism diagnoses by clinical experts. Further evaluation of this test's role in early diagnosis and assessment of autism in routine specialty clinic practice is warranted. Trial Registration: ClinicalTrials.gov Identifier: NCT03469986.

Indexed as

Autistic DisorderEye-Tracking TechnologySocial BehaviorVisual PerceptionAmbulatory Care FacilitiesAsianChild, PreschoolEye MovementsHumansInfant

Identifiers

PMID37668621
PMCPMC10481242
OpenAlexW4386438037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.